HL7 Terminology (THO)
6.1.0 - Publication
This page is part of the HL7 Terminology (v6.1.0: Release) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version. For a full list of available versions, see the Directory of published versions
Active as of 2023-07-28 | Maturity Level: 1 |
{
"resourceType" : "ValueSet",
"id" : "adverse-event-clinical-research-grades",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/StructureDefinition/shareablevalueset"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet adverse-event-clinical-research-grades</b></p><a name=\"adverse-event-clinical-research-grades\"> </a><a name=\"hcadverse-event-clinical-research-grades\"> </a><a name=\"adverse-event-clinical-research-grades-en-US\"> </a><ul><li>Include these codes as defined in <a href=\"CodeSystem-v3-nciThesaurus.html\"><code>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>C41338</td><td>Grade 1 Mild Adverse Event</td></tr><tr><td>C41339</td><td>Grade 2 Moderate Adverse Event</td></tr><tr><td>C41340</td><td>Grade 3 Severe Adverse Event</td></tr><tr><td>C41337</td><td>Grade 4 Life Threatening or Disabling Adverse Event</td></tr><tr><td>C48275</td><td>Grade 5 Death Related to Adverse Event</td></tr></table></li></ul></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode" : "brr"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger" : 1
}
],
"url" : "http://terminology.hl7.org/ValueSet/adverse-event-clinical-research-grades",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.11.21027"
}
],
"version" : "1.0.0",
"name" : "AdverseEventClinicalResearchGrades",
"title" : "Adverse Event Clinical Research Grades",
"status" : "active",
"experimental" : false,
"date" : "2023-07-28T19:27:19+00:00",
"publisher" : "Health Level Seven International",
"contact" : [
{
"telecom" : [
{
"system" : "url",
"value" : "http://hl7.org"
},
{
"system" : "email",
"value" : "hq@HL7.org"
}
]
}
],
"description" : "Value set of grades used in Adverse Event Clinical Research, especially in Oncology clinical trials",
"copyright" : "This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html",
"compose" : {
"include" : [
{
"system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"concept" : [
{
"code" : "C41338",
"display" : "Grade 1 Mild Adverse Event"
},
{
"code" : "C41339",
"display" : "Grade 2 Moderate Adverse Event"
},
{
"code" : "C41340",
"display" : "Grade 3 Severe Adverse Event"
},
{
"code" : "C41337",
"display" : "Grade 4 Life Threatening or Disabling Adverse Event"
},
{
"code" : "C48275",
"display" : "Grade 5 Death Related to Adverse Event"
}
]
}
]
}
}